Regulatory mechanisms for retinal ganglion cell genesis

视网膜神经节细胞发生的调节机制

基本信息

  • 批准号:
    10682105
  • 负责人:
  • 金额:
    $ 47.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2028-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract How individual retinal cell types arise from retinal progenitor cells (RPCs) is an active field of research, as it is critical to understanding the generation of cellular diversity in the retina and developing therapeutic strategies to treat degenerative retinal diseases. Many transcription factors involved in the generation of individual retinal cell types have been identified. Single-cell technologies have led to unprecedented progress in discerning the cellular relationships of the different lineage trajectories and the underlying changes in the epigenetic landscape. The roles of individual transcription factors in shaping the epigenetic landscape to drive multipotent RPCs to specific fates are also beginning to be revealed. A major finding from the single-cell RNA-seq studies is that all the retinal lineages undergo a shared state, namely transitional RPCs (tRPCs), before fate determination. tRPCs are multipotent and co-express genes involved in the different retinal cell types such as Atoh7 for RGCs and Otx2 and Neurod1 for photoreceptors. Our mapping of binding sites for Atoh7 and Otx2 by CUT&Tag suggests a general paradigm via which the co-expressed transcription factors compete at enhancers of lineage-specific genes to drive tRPCs to different cell fates. The focus of our lab has been on the mechanisms controlling RGC genesis. In this application, we propose to address several key knowledge gaps regarding the emergence of the RGC lineage from tRPCs. The first is the missing branch of upstream input as indicated by our scRNA- seq analysis of the Atoh7-null retina. We hypothesize that the SoxC factors fulfill this role by function in parallel with Atoh7 to promote RGC genesis based on previous findings on the roles of the SoxC factors in RGC genesis. The second gap we aim to address is the molecular basis for the specificity of Atoh7 for the RGC lineage. This is based on the fact that several proneural bHLH transcription factors, including Atoh7 and Neurod1, which all bind to the E box motif, are co-expressed in tRPCs, but only Atoh7 promotes RGC formation. Using ectopic expression in retinal explants, we have obtained compelling evidence which suggests that the RGC-specificity of Atoh7 resides in the bHLH domain. We will further explore the molecular basis for the RGC specificity of Atoh7 in vivo using knockin mouse lines. Lastly, we will investigate the regulatory mechanisms leading to the fixation of the RGC fate. We will leverage the candidate enhancers identified from our scATAC-seq and CUT&Tag experiments for the key RGC specific transcription factor gene Pou4f2 and examine their contributions to the eventual expression of Pou4f2. Our experiments are designed to address these gaps using a combined approach of mouse genetics, immunohistochemistry, genomics, transcriptomics, and single cell techniques. These proposed experiments aim to understand key gene regulatory events controlling the emergence of the RGC lineage from tRPCs. The findings will lead to further insights into the molecular basis underpinning the cellular diversity in the retina and offer guidance for developing strategies to treat degenerative retinal diseases.
项目总结/摘要 单个视网膜细胞类型如何从视网膜祖细胞(RPC)中产生是一个活跃的研究领域,因为它是 对于理解视网膜细胞多样性的产生和开发治疗策略至关重要 来治疗视网膜退化疾病许多转录因子参与个体视网膜色素瘤的产生, 细胞类型已经确定。单细胞技术已经导致了前所未有的进步, 不同谱系轨迹的细胞关系和表观遗传景观的潜在变化。 单个转录因子在塑造表观遗传景观以驱动多能RPC中的作用 具体的命运也开始揭晓。单细胞RNA-seq研究的一个主要发现是, 在命运决定之前,视网膜谱系经历一种共享的状态,即过渡性RPC(tRPC)。tRPC 是多能的,并且共表达涉及不同视网膜细胞类型的基因,例如RGC的Atoh 7和Otx 2 和Neurod 1用于光感受器。我们通过CUT&Tag绘制的Atoh 7和Otx 2结合位点的图谱表明, 共表达的转录因子竞争谱系特异性基因的增强子的一般范例 驱动tRPC走向不同的细胞命运。我们实验室的重点是控制RGC发生的机制。 在这个应用程序中,我们提出解决几个关键的知识差距, 从tRPC中分离出RGC谱系。第一个是上游输入的缺失分支,如我们的scRNA所示- Atoh 7无效视网膜的seq分析。我们假设SoxC因子通过平行的功能来履行这一角色 基于先前关于SoxC因子在RGC发生中的作用的发现,用Atoh 7促进RGC发生。 我们旨在解决的第二个缺口是Atoh 7对RGC谱系特异性的分子基础。这是 基于几种前神经bHLH转录因子,包括Atoh 7和Neurod 1, 与E盒基序结合,在tRPC中共表达,但只有Atoh 7促进RGC形成。使用异位 我们已经获得了令人信服的证据,表明RGC特异性的视网膜移植, Atoh 7位于bHLH结构域中。我们将进一步探索Atoh 7的RGC特异性的分子基础, 在体内使用敲入小鼠系。最后,我们将研究导致固定的调节机制 RGC的命运。我们将利用从scATAC-seq和CUT&Tag中鉴定的候选增强子 实验的关键RGC特异性转录因子基因Pou 4f 2,并检查他们的贡献, Pou 4f 2的最终表达。我们的实验旨在使用组合方法来解决这些差距 小鼠遗传学、免疫组织化学、基因组学、转录组学和单细胞技术。这些 提出的实验旨在了解控制RGC出现的关键基因调控事件 来自tRPC的谱系。这一发现将进一步深入了解支撑细胞免疫的分子基础。 视网膜的多样性,并为制定治疗退行性视网膜疾病的策略提供指导。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genetic control of retinal ganglion cell genesis.
Single cell transcriptomics reveals lineage trajectory of retinal ganglion cells in wild-type and Atoh7-null retinas.
  • DOI:
    10.1038/s41467-021-21704-4
  • 发表时间:
    2021-03-05
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Wu F;Bard JE;Kann J;Yergeau D;Sapkota D;Ge Y;Hu Z;Wang J;Liu T;Mu X
  • 通讯作者:
    Mu X
Isl1 and Pou4f2 form a complex to regulate target genes in developing retinal ganglion cells.
  • DOI:
    10.1371/journal.pone.0092105
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Li R;Wu F;Ruonala R;Sapkota D;Hu Z;Mu X
  • 通讯作者:
    Mu X
miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes.
  • DOI:
    10.1186/1471-2164-13-44
  • 发表时间:
    2012-01-25
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Bruno AE;Li L;Kalabus JL;Pan Y;Yu A;Hu Z
  • 通讯作者:
    Hu Z
Genetic interactions between Brn3 transcription factors in retinal ganglion cell type specification.
  • DOI:
    10.1371/journal.pone.0076347
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Shi M;Kumar SR;Motajo O;Kretschmer F;Mu X;Badea TC
  • 通讯作者:
    Badea TC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiuqian Mu其他文献

Xiuqian Mu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiuqian Mu', 18)}}的其他基金

Regulation of mRNA decay in retinal development and maintenance
视网膜发育和维护中 mRNA 衰减的调节
  • 批准号:
    10368133
  • 财政年份:
    2020
  • 资助金额:
    $ 47.33万
  • 项目类别:
Regulation of mRNA decay in retinal development and maintenance
视网膜发育和维护中 mRNA 衰减的调节
  • 批准号:
    10580686
  • 财政年份:
    2020
  • 资助金额:
    $ 47.33万
  • 项目类别:
Regulatory mechanisms for retinal ganglion cell genesis
视网膜神经节细胞发生的调节机制
  • 批准号:
    10171855
  • 财政年份:
    2011
  • 资助金额:
    $ 47.33万
  • 项目类别:
Interaction of Isl1 and Pou4f2 in retinal development
Isl1 和 Pou4f2 在视网膜发育中的相互作用
  • 批准号:
    8107291
  • 财政年份:
    2011
  • 资助金额:
    $ 47.33万
  • 项目类别:
Interaction of Isl1 and Pou4f2 in retinal development
Isl1 和 Pou4f2 在视网膜发育中的相互作用
  • 批准号:
    8624696
  • 财政年份:
    2011
  • 资助金额:
    $ 47.33万
  • 项目类别:
Interaction of Isl1 and Pou4f2 in retinal development
Isl1 和 Pou4f2 在视网膜发育中的相互作用
  • 批准号:
    8232009
  • 财政年份:
    2011
  • 资助金额:
    $ 47.33万
  • 项目类别:
Interaction of Isl1 and Pou4f2 in retinal development
Isl1 和 Pou4f2 在视网膜发育中的相互作用
  • 批准号:
    8435515
  • 财政年份:
    2011
  • 资助金额:
    $ 47.33万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.33万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了